Cases & Deals

  • Home
  • Practices
  • Baxalta merges with Shire in $32 billion biotechnology deal

Share

Baxalta merges with Shire in $32 billion biotechnology deal

June 2016

Client(s) Baxalta Incorporated

Jones Day represented Baxalta Incorporated, a biopharmaceutical manufacturer headquartered in Northern Illinois, as global antitrust and competition law counsel in its $32 billion merger with Ireland based Shire plc to create a leading biotechnology company focused on treatments for rare diseases.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.